It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Tight control of cell fate choices is crucial for normal development. Here we show that lamin A/C plays a key role in chromatin organization in embryonic stem cells (ESCs), which safeguards naïve pluripotency and ensures proper cell fate choices during cardiogenesis. We report changes in chromatin compaction and localization of cardiac genes in Lmna−/− ESCs resulting in precocious activation of a transcriptional program promoting cardiomyocyte versus endothelial cell fate. This is accompanied by premature cardiomyocyte differentiation, cell cycle withdrawal and abnormal contractility. Gata4 is activated by lamin A/C loss and Gata4 silencing or haploinsufficiency rescues the aberrant cardiovascular cell fate choices induced by lamin A/C deficiency. We uncover divergent functions of lamin A/C in naïve pluripotent stem cells and cardiomyocytes, which have distinct contributions to the transcriptional alterations of patients with LMNA-associated cardiomyopathy. We conclude that disruption of lamin A/C-dependent chromatin architecture in ESCs is a primary event in LMNA loss-of-function cardiomyopathy.
LMNA mutations cause severe heart dysfunction. Here the authors show that Lamin A/C plays a key role in 3D chromatin architecture in naïve pluripotent stem cells, which ensures proper cardiovascular cell fate and function, and shed light on the mechanisms involved in LMNA cardiomyopathies.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Heidelberg University, Department of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Mannheim, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373); German Centre for Cardiovascular Research (DZHK), Mannheim, Germany (GRID:grid.452396.f) (ISNI:0000 0004 5937 5237)
2 Heidelberg University, Department of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Mannheim, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373)
3 German Centre for Cardiovascular Research (DZHK), Mannheim, Germany (GRID:grid.452396.f) (ISNI:0000 0004 5937 5237); Heidelberg University, Department of Cardiovascular Physiology, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Mannheim, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373)
4 German Centre for Cardiovascular Research (DZHK), Mannheim, Germany (GRID:grid.452396.f) (ISNI:0000 0004 5937 5237); Heidelberg University, Department of Cardiovascular Physiology, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Mannheim, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373); Medical Faculty University of Bonn, Institute of Physiology I, Life & Brain Center, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300)
5 University Medical Centre Mannheim (UMM), Heidelberg University, First Department of Medicine, Faculty of Medicine, Mannheim, Germany (GRID:grid.411778.c) (ISNI:0000 0001 2162 1728); Ruhr University, Bergmannsheil Bochum, Medical Clinic II, Department of Cardiology and Angiology, Bochum, Germany (GRID:grid.5570.7) (ISNI:0000 0004 0490 981X)
6 German Centre for Cardiovascular Research (DZHK), Mannheim, Germany (GRID:grid.452396.f) (ISNI:0000 0004 5937 5237); Heidelberg University, Institute of Experimental Cardiology, Medical Faculty Heidelberg, Heidelberg, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373)
7 German Centre for Cardiovascular Research (DZHK), Mannheim, Germany (GRID:grid.452396.f) (ISNI:0000 0004 5937 5237); Heidelberg University, Experimental Pharmacology, European Center for Angioscience, Medical Faculty Mannheim, Mannheim, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373)